Online resource for AMD

Article

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.EyeScience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.eyescience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

The site contains basic eye anatomy, screening and diagnosis, risk factors, signs and symptoms and treatments for AMD. There are also more than 20 watch-and-learn videos about eye anatomy, AMD symptoms, dry and wet macular degeneration, diagnostic tests, photodynamic therapy (PDT), intravitreal injection of Lucentis and Avastin, vitamin therapy, amsler grid testing, lasers and more.

Users also have the ability to browse an FAQ section, which contains expert answers to more than 30 questions about AMD. An additional feature is an 'Ask the Doctor' section where browsers can submit their questions about AMD or problems they may personally be experiencing with their eyes and EyeScience medical experts will answer them privately and free-of-charge.

Visit the site at www.eyescience.com and let us know what you think at www.oteurope.com/discuss

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.